Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot - ballot International flag

This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions

Example EvidenceVariable: GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis

Active as of 2023-12-17

Generated Narrative: EvidenceVariable

Resource EvidenceVariable "179784" Version "3" Updated "2023-12-01 22:26:01+0000"

Profile: GroupAssignment

EvidenceVariableDefinition: Defined in handling and category elements (Evidence Based Medicine on FHIR Implementation Guide Code System#defined-in-handling-and-category)

StructureDefinition Work Group: cds

url: https://fevir.net/resources/EvidenceVariable/179784

identifier: FEvIR Object Identifier: 179784

version: 1.0.0-ballot

name: Therapeutic_dose_anticoagulation_with_heparin_vs_Usual_care_pharmacologic_thromboprophylaxis

title: GroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis

status: active

date: 2023-12-17 16:55:23+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis in multi-platform RCT of anticoagulation for non-critically ill patients with COVID-19

UseContexts

-CodeValue[x]
*Evidence Communication (Details: https://fevir.net/resources/CodeSystem/179423 code evidence-communication = 'Evidence Communication', stated as 'Evidence Communication')group-assignment ()

copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/

author: Brian S. Alper:

RelatedArtifacts

-TypeCitation
*cite-asGroupAssignment: Therapeutic-dose anticoagulation with heparin vs. Usual-care pharmacologic thromboprophylaxis [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 179784. Revised 2023-11-30. Available at: https://fevir.net/resources/EvidenceVariable/179784. Computable resource at: https://fevir.net/resources/EvidenceVariable/179784.

handling: dichotomous

category

EvidenceVariableCategoryValueReference: Group/179786: ExposureDefinition: Therapeutic-dose anticoagulation with heparin "ExposureDefinition_Therapeutic_dose_anticoagulation_with_heparin"

name: Therapeutic-dose anticoagulation with heparin

category

EvidenceVariableCategoryValueReference: Group/179785: ComparatorDefinition: Usual-care pharmacologic thromboprophylaxis "ComparatorDefinition_Usual_care_pharmacologic_thromboprophylaxis"

name: Usual-care pharmacologic thromboprophylaxis